Please assess the completion status of the following clinical trial:

Trial Title: Bevacizumab for Neovascular Age-related Macular Degeneration

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of neovascular Age-related macular degeneration~* Signed informed consent~Exclusion Criteria:~* No other ocular fundus diseases

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Bevacizumab 1 (Type: ACTIVE_COMPARATOR): None
- Bevacizumab 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).